| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8229158 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 8 Pages |
Abstract
PPC at the time of biopsy adds prognostic value for clinically meaningful endpoints for patients treated with dose-escalated radiation therapy. This was particularly true for NCCN-defined intermediate- and high-risk patients.
Keywords
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yushen B.S., Felix Y. M.D., Schuyler B.S., Kevin B.S., Howard M. M.D., Daniel A. M.D., Ph.D.,